Tags:BioTechDevelopmentDrugManagementManufacturingMedTechPlatformResearchServiceTime
Outsourcing made easy with a one-stop solution to early phase drug development. We are an integrated drug development solution company, offering pharmaceutical and biotechnology companies a proven, flexible approach that removes the need for multiple service providers during the early stages of drug development. Whether for one study or an end-to-end program, we help you reach critical decision-making milestones sooner by improving speed and ease from lead candidate selection to clinical proof of concept, and beyond. When partnering with Altasciences, you can experience up to 40% in time savings thanks to our integrated, one-stop solution offering. We strive to create a true partnership with our clients, our partners, and our colleagues that enables a mutually supporting relationship built on a combination of excellent science and solid communication. Helping sponsors get better drugs to the people who need them, faster, for over 25 years. Our full-service offering is always tailored to your specific research needs: - Preclinical research - Clinical pharmacology - Drug formulation - Manufacturing and analytical services - Bioanalysis - Program management - Medical writing - Biostatics - Data management - And so much more!
Location: United States, Pennsylvania, Scott
Member count: 1001-5000
Founded date: 1992

Investors 1

Mentions in press and media 25

DateTitleDescriptionCategoryAuthorSource
17.01.2022Altascienc...LAVAL, Quebec--(BUSINESS WIRE)...--signetheal...
07.01.2022Fu­ji­film...New year, same Fu­ji­film Dios...-Josh Sulli...endpts.com...
06.01.2022Pfiz­er an...Throughout the past two years,...-Zachary Br...endpts.com...
06.01.2022John Marag...On his way out of Al­ny­lam, o...-Paul Schlo...endpts.com...
06.01.2022A year af­...Al­ta­sciences CEO Chris Perki...-Josh Sulli...endpts.com...
06.01.2022So­sei and...So­sei Hep­tares is team­ing u...-Paul Schlo...endpts.com...
06.01.2022Pfiz­er an...Eli Lilly is beefing up its fl...-Zachary Br...endpts.com...
06.01.2022Pfiz­er an...Alnylam was a few years ahead ...-Zachary Br...endpts.com...
06.01.2022No­vo Hold...Roger Perlmutter hasn’t wasted...-Josh Sulli...endpts.com...
06.01.2022Fore­site'...A Fore­site-in­cu­bat­ed biote...FinancingMax Gelmanendpts.com...
Show more